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1. THE THESIS BACKGROUND AND OBJECTIVES 
 
In the last decades, our knowledge of normal and abnormal vascular functions 
has increased explosively. Nowadays it is well known that the complex system of 
human vasculature encompasses the endothelial and blood cells as well as the 
interaction and dynamic change of neurogenic and non-neurogenic regulatory 
mechanism. Raynaud's syndrome is an ideal for investigating functional disorders of 
circulatory system, due to its high prevalence and spectacular clinical picture. 
The present dissertation summarizes my findings on vascular abnormalities and 
prothrombotic characteristics in primary Raynaud's syndrome. 
 
 
1.1. Raynaud’s phenomenon 
 
Raynaud’s phenomenon is an excessively reduced blood flow in response to cold 
or emotional stress, causing discoloration of the fingers, toes, and occasionally other 
areas. The disorder behind this symptom is referred as Raynaud’s syndrome (RS). Three 
color changes are observed in classic Raynaud's. (1) When exposed to cold 
temperatures, the blood supply to the fingers or toes, and in some cases the nose or 
earlobes, is markedly reduced; the skin turns pale or white (called pallor) and becomes 
cold and numb. (2) When the oxygen supply is depleted, the skin color turns blue 
(called cyanosis). These events are episodic, and (3) when the episode subsides or the 
area is warmed, the blood flow returns, and the skin color first turns red (rubor), and 
then back to normal, often accompanied by swelling, tingling, and a painful "pins and 
needles" sensation.  
However, not all patients see all of the aforementioned color changes in all 
episodes, especially in milder cases of the condition. The attack usually lasts a few 
minutes, but in some cases there may be up to several hours, the mean duration of 20-25 
minutes. Initially, usually only few fingers are affected, but later, along with the disease 
progression, RS may affect all fingers of both hand. Symptoms of toes, tongue, nose, 
earlobes, or nipples are less common. 
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1.2. The clinical characteristics of Raynaud's syndrome 
 
 When the disorder's cause is idiopathic, it is referred to as primary Raynaud's 
syndrome; if the syndrome is secondary to another disease such as systemic sclerosis 
(SSc), or other connective tissue disorders, it is referred to as secondary Raynaud's 
syndrome. In primary form, the fingers are usually affected symmetrically, with pure 
vasospastic attack in the background, without any structural damage in digital arteries. 
Primary RS patients are more likely to have migraines and angina. 
Secondary RS with the organic digital artery lesions can be associated with 
immunological diseases [eg. systemic sclerosis, systemic lupus erythematosus (SLE)], 
haematological malignant diseases, diabetes, carpal tunnel syndrome or even thoracic 
outlet syndrome. Furthermore, various drugs (beta-blockers, amphetamines, ergotamine, 
bleomycin, vinblastine, cyclosporin) may also trigger RS. In older patients, obstructive 
vascular disease is the most common reason. In addition to the aforementioned factors, 
occupational hazards (vibrations, polyvinyl chloride) can cause Raynaud's syndrome, as 
well. 
The true incidence of Raynaud's syndrome is unknown; the prevalence is 
estimated at 5-20% of the European adult population. The Raynaud's syndrome is four 
times more common in women than in men. The role of hormonal factors is supported 
by several observations, and after menopause, symptoms of primary RS often disappear. 
Secondary Raynaud's syndrome may occur at any age depending on the basic 
disease, although the beginning is more common in older age. The incidence of the 
associated diseases also increases with the age. Raynaud's phenomenon is usually one of 
the initial symptoms of systemic sclerosis, which may be preceded by years of other 
signs of the disease (90-95% prevalence). In SLE and Sjögren's syndrome, 35-39% of 
the patients suffer from Raynaud's syndrome.  
 
 
1.3. The pathophysiology of Raynaud's syndrome  
 
In Raynaud's syndrome, cold and stress lead to excessive vascular response resulting in 
decreased perfusion in the affected areas. The proper microcirculation is critically 
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dependent on the integrity of the endothelium, the appropriate regulation of vascular 
tone and the characteristics of plasma and cellular components of blood. The etiology of 
primary Raynaud’s phenomenon (PRP) is not entirely known. Abnormalities in the 
blood vessel wall, as well as in the neural control of vascular tone, and in some 
circulating mediators were found as part of the pathophysiology of this phenomenon.  
 
Structural and functional changes of the vascular wall 
The endothelial cells, beside their physical barrier function, play an outstanding 
role in the regulation of circulation by producting and releasing various cytokines and 
other factors. Alteration in endothelium-dependent processes, such as overexpression of 
vasoconstrictor mediators (eg. Endothelin-1, Thromboxane A2) and decrease in release 
of vasodilator factors (NO, prostacyclin) can play a key role in the development of 
Raynaud's phenomenon. 
In contrast with the primary form with purely functional differences, in 
secondary RS associated with autoimmune disease, elevated endothelial vasoconstrictor 
factors along with the activation of immune cells and pro-inflammatory cytokine milieu 
result in the structural damage of blood vessels. One of the first steps in the disease 
process is the development of endothelial lesions, such as vacuolar degeneration of 
endothelial cells and damage of basal membrane. Activation of immune system and 
derailed inflammatory responses lead to structural damage of vessel wall, hypertrophy 
of tunica intima and media and fibrosis in advetitia. The worsening circulatory 
disturbance may cause hypoxic condition in the affected tissues, which can lead to the 
formation of reactive oxygen species, activation of fibroblasts and further release of 
growth factors. These processes lead to progressive narrowing of vessel lumen, later 
occlusion and subsequent tissue and organ damage may occur. 
 
Neurogenic disorders 
The autonomic nervous system, which is a key element of the body's thermal 
regulation, is believed to play a role in the development of Raynaud’s phenomenon. The 
vascular smooth muscle may overreact to normal sympathetic impulses. Additionally, 
increased release of noradrenaline from sympathetic nerves, impaired catecholamine 
degradation, increased density or affinity of alpha adrenoceptors, decreased density or 
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affinity of beta-2 adrenoceptors, as well as a shift of second messengers such as cAMP, 
cGMP calcium ions may be important. Freedman et al. reported that peripheral alpha-
adrenoceptor sensitivity or density is increased in primary Raynaud syndrome. The 
alpha-2 adrenergic play a key role in vascular tone regulation of the fingers. Previous 
studies demonstrated that enhanced reactivity of alpha-2 adrenoceptor can be detected 
in arteriolar smooth muscle in systemic sclerosis associated secondary RS. Changes in 
adrenoceptor activity was also reported in chronic vibration caused RS. 
Vasodilator effect of autonomic nervous system can be also insufficient. 
Calcitonin gene related peptide (CGRP) is an endogenous vasodilator. A significant 
decrease in CGRP-responsive neurons was revealed in skin biopsy of both primary and 
secondary RS patients. The emotional loading induced vasospasm may be due to the 
excessive central activation of sympathetic system. 
 
Intravascular factors - platelets, prothrombotic factors 
A number of intravascular factors play role in the development of Raynaud's 
phenomenon, such as leukocyte activation, altered cytokine milieu and release of 
reactive oxygen radicals.  
Enhanced platelet activation was reported in both primary and secondary RS. 
Platelets release a surprisingly large array of mediators, many of which have important 
roles in inflammation, tissue repair and vascular function. The platelet-derived 
mediators potentially contribute to chemotaxis, cellular adhesion, altered vascular 
resistance, altered vascular permeability, angiogenesis, matrix degradation and fibrosis. 
Platelets are a rich source of chemokine (C-C motif) ligand 5 (CCL5), platelet 
factor (PF)-4, beta- thromboglobulin (TG) and epithelial neutrophil activating protein 
(ENA)-78. Each has important leukocyte–chemoattractant properties attracting 
neutrophils, eosinophils, monocytes and fibroblasts to the sites of inflammation. Platelet 
granules also release several important pro-inflammatory mediators, such as interleukin 
(IL)-1beta, CD40 ligand, platelet-derived growth factors (PDGF). P-selectin (also 
known as CD62P) is a single-chain transmembrane glycoprotein from a family of 
important cell adhesion molecules. P-selectin translocates to the platelet membrane 
following activation, facilitating adhesion, aggregation and leukocyte recruitment. P-
selectin is the primary receptor for the interaction between platelets and monocytes, 
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neutrophils, memory T-cells and natural killer cells, modulating chemokine and 
cytokine expression in these cells. Additionally, platelets are a rich source of pro-
angiogenic and pro-fibrotic growth factors, including transforming growth factor-beta 
(TGF-beta) and platelet-derived growth factors (PDGF), as well.  
Based on these observations, increased platelet activation and their altered 
function may play a potential role in the pathogenesis of Raynaud's syndrome. Studies 
have shown increased platelet aggregation ability ex vivo in primary Raynaud's 
syndrome as well as systemic sclerosis associated secondary form. Mean platelet 
volume (MPV) and platelet P-selectin are considered as two sensitive markers of 
elevated platelet activation. Increased MPV and CD62P levels have been formerly 
described in inflammation, hyperlipidemia, myocardial infarction, diabetes mellitus, 
hypertension, and autoimmune diseases such as rheumatoid arthritis. However, the 
clinical value of MPV in primary RS is still unclear. 
The von Willebrand factor (vWF) is a large multimeric glycoprotein produced 
by many cells including endothelial cells and platelets, facilitating platelet adhesion and 
aggregation. Several studies have reported increased circulating levels of vWF in SSc, 
variously reporting their pathological significance in terms of either platelet or 
endothelial cell activation. Several other studies examined the association between 
plasma levels of vWF and fibrinogen levels in patients with primary RS, however their 
results were controversial. 
Thrombophilia may develop due to acquired homeostasis changes and/or 
inherited genetic factors. Factor V substitution of G to A at position 1691 (FVLeiden), 
is the most common risk factor for venous thrombosis with frequency of 1–11% in 
Europeans and associated with thrombotic angiopathy. The prothrombin G20210A 
polymorphism (FIIG20210A) the substitution of G for A at position 20210 has 0.7–4.0 
% prevalence in normal population while it is responsible for 6.2 % of all cases of 
thrombosis and associated with elevated prothrombin plasma activity. Gene variant in 
the methylenetetrahydrofolate reductase gene (MTHFR 677C>T polymorphism) is a 
risk factor for venous and arterial thrombosis which is more prevalent in patients with 
cardiovascular disease (17 %) than in the normal population (5 %). Carriers for MTHFR 
T677T mutation have increased total homocysteine (Hcy) levels. Besides, increased 
levels of homocysteine have been found in patients with primary RS. Higher Hcy level 
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increases the risk of endothelial injury in these patients, consequently, may affect the 
threshold of migraine headache. A common polymorphism in the FXIII-A gene-V34L 
is an important functional polymorphism described in the hemostatic system. This 
polymorphism affects a valine residue, 3 amino acids upstream to the thrombin cleavage 
site. It has been clearly demonstrated that the higher rate of proteolytic truncation of 
L34 variant resulted in earlier activation of FXIII and, consequently, accelerated the 
cross-linking of fibrin. Moreover, this polymorphism also has a significant effect on 
fibrin clot structure, probably through the alteration of fibrin cross-linking kinetic. Its 
prevalence is about 25 % among Caucasians, and in blacks and Asian Indians the allele 
frequency is lower. The higher prevalence of vascular injury besides genetic 
predisposition to thrombosis could partly explain the presence of migraine in this group 
of patients.  
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1.4. Objectives 
 
Platelet studies of primary Raynaud's syndrome 
 
In our work, we investigated the role of platelets in the pathogenesis of primary 
Raynaud's syndrome. The results obtained from patients were compared to healthy 
control subjects’ data. As the role of platelets in primary RS is controversial, the 
objectives of our investigations were determined as follows: 
1) Comparison of the number and mean volume of circulating peripheral platelets 
in patients with primary RS with the corresponding values of healthy controls. 
2) Comparison of the platelet activation and CD62P expression measured in 
patients and control individuals.  
3) Examination of the relationships between the observed laboratory results and the 
demographic and clinical characteristics of patients. 
 
 
Von Willebrand factor and fibrinogen tests 
 
In our study, we examined the potential role of fibrinogen and von Willebrand 
factor in blood clotting process in the pathogenesis of primary Raynaud's syndrome. 
Previous studies did not find any association between PRP and vWF and fibrinogen 
levels. However, they were not only based on small number of subjects, but also their 
studies did not investigate this association between men and women separately. Since 
the possible relationship between these factors and primary RS is still not 
fully elucidated. Our objectives were as follows:  
1) Determination of von Willebrand factor and fibrinogen levels in a large number 
of primary RS patients. 
2) Comparison of the measured values between the male and female populations. 
3) Examination the risk role of higher von Willebrand factor and fibrinogen levels 
in the development of primary RS. 
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Prothrombotic polymorphism analysis 
 
Many previous studies reported on the links between the alterations occurring in 
the blood coagulation system and the vascular dysfunction, which may lead to the 
development of various vasospastic disease conditions including Raynaud's syndrome, 
Prinzmetal's angina and migraine. In our study, we investigated the role of genetic 
factors predisposing to thrombosis in the development of migraine in patients with 
primary Raynaud's syndrome. Our objectives were as follows: 
1) Detection of the factor V Leiden mutation (G and A exchange at position 1691) 
in primary RS patients. 
2) Detection of the G20210A prothrombin polymorphism (FII G20210A) in the 
patients. 
3) Examination of the methylenetetrahydrofolate reductase (MTHFR) gene C677T 
mutation in the patient population. 
4) Determining factor VIII (Laki-Lóránd factor) V34L mutations among patients. 
5) Comparison of the laboratory results with a special emphasis on the association 
of migraine. 
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2. PATIENTS AND METHODS 
 
2.1. Patients 
 
Patients were recruited from the Autoimmune Outpatient Clinic of the Division 
of Clinical Immunology, Institute of Medicine, Clinical Center, University of Debrecen, 
where they received regular follow-up and treatment. Two hundred patients (158 
female, 42 male, mean age of 42.4 ± 13.7 years) with the diagnosis of PRP were 
included in the study. The diagnosis of RS was based according to the criteria by 
Wigley et al. The diagnosis included a detailed history taking and the observation of 
bilateral, cold-induced blanching and/or cyanosis of the fingers, or in some cases that of 
toes as well. We performed a complete serologic examination to detect and exclude the 
development of any primary connective tissue disease causing secondary RS. 116 age-
matched clinical controls without any chronic disease were enrolled (77 female, 39 
male, mean age of 41.6 ± 14.0 years). Patients and controls were the subjects of the 
same geographical and ethnic origin.  
In this study, we did not include patients with anamnestical occurrence of 
angina, myocardial infarction, diabetes mellitus, thrombosis, or connective tissue 
disease. 
Patients were followed up for a mean ± S.D. of 4 ± 3.5 years. In our study group, 
29% of the patients had a history of migraine. Hyperlipidemia was defined when serum 
cholesterol level was more than 5.2 mmol/l and/or triglyceride level was more than 1.7 
mmol/l and/or regular administration of lipid-lowering agents. Hyperlipidemia ratio was 
similar (55% vs. 47%) in patients and controls. Notably, there was no significant 
difference in term of regular statin treatment among patients and controls, and they were 
not under any medication that influenced the function of bone marrow or platelets for at 
least three months prior to the sampling. No patients, or controls enrolled in this study 
were administered immunosuppressive or immune-modulating medications and no one 
had ongoing infections, either viral, or bacterial. During the study, serum CRP levels of 
the enrolled subjects were within the reference range (<10 mg / L). 
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Informed written consent was obtained from the subjects, and the study has been 
approved by the Ethics Committee of University of Debrecen. All experiments carried 
out were in compliance with the Helsinki Declaration. 
 
 
2.2. General laboratory tests 
 
EDTA anticoagulated whole blood samples were analyzed by the Sysmex SF-
3000 analyzer (Sysmex Corporation, Kobe, Japan). The samples were processed within 
two hours after venipuncture. Fasting serum samples were taken for the determination 
of lipid parameters and C-reactive protein (CRP) and measured on COBAS Integra 
Analyzer (Roche, Mannheim, Germany) in the Department of Laboratory Medicine of 
the University of Debrecen. 
 
 
2.3. Determination of autoantibodies 
 
The determination of autoantibodies was carried out by indirect 
immunofluorescence technique on Hep2 cells with IFA ANA-Hep2-IgG 
immunofluorescence kit (Viro-Immun Labor-Diagnostika GmbH, Oberursel, Germany) 
at the Regional Immunology Laboratory of the Division of Clinical Immunology of the 
University of Debrecen. To identify fluorescence patterns, Eurostar Plus II fluorescence 
microscope (EUROIMMUN AG, Lübeck, Germany) was used. 
Enzyme-linked immunosorbent assay (ELISA) screening tests for extractable 
nuclear antigen (ENA) antibodies were also carried out, and in case of positivity, 
specific determination of antibodies against Sm, Sm/RNP, SS-A, SS-B, Scl-70, Jo-1 
was performed by ELISA technique with AUTOSTAT II kits (Hycor Biomedical, 
Indianapolis, IN, USA), according to the manufacturer’s instructions. ETI-MAX 300 
device (Diasorin, Saluggia, Italy) was used for the measurements and data evaluation. 
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2.4. Flow cytometry assay 
 
Platelets were identified by a fluorescein isothiocyanate (FITC)-conjugated 
monoclonal antibody to CD42a. Platelet activation was detected by phycoerythrin (PE)-
labeled anti-CD62P antibody (Becton Dickinson, San Jose, CA, USA). 40 l of all 
anticoagulated peripheral blood samples were fixed in 1 ml 1 % paraformaldehyde. The 
samples were centrifuged and the pellet was washed in 1 ml phophate-buffered saline 
(PBS). Fixed platelets were incubated with monoclonal antibodies for 20 min in the 
dark at room temperature. Ten thousand dual-color labelled platelet events were 
acquired on FACS Calibur flow cytometer by using the CellQuest 3.2 software (Becton 
Dickinson). Results were expressed as percentage of circulating positive platelets. 
 
 
2.5. Determination of von Willebrand factor and fibrinogen levels 
 
Hemostasis tests and determination of plasma fibrinogen levels of sodium citrate 
anticoagulated peripheral blood were made by using BCS XP device (Siemens 
Healthcare Diagnostics, Deerfield, IL, USA).  
The vWF levels were determined by ELISA according to the manufacturer’s 
instructions in the Department of Laboratory Medicine of the University of Debrecen.  
 
 
2.6. Genetic polymorphism analysis  
 
Genomic DNA was isolated by using MagNA Pure LC Instrument (Roche Diagnostics) 
according to manufacturer’s protocol. To detect the G1691A mutation in Factor V 
gene,G20210A mutation in Factor II, C677T mutation in MTHFR gene, and FXIII-A 
V34L the real-time fluorescence PCR were performed as described earlier by using 
LightCycler (Roche Diagnostics). 
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2.7. Statistical analyses 
 
The SPSS ver. 12.0 and 13.0 (SPSS Inc., Chicago, IL, UDA) was used for 
statistical analysis. To assess the distribution of data Kolgomorov-Smirnov test was 
used. In cases of normal distribution, we determined mean ± standard deviation (SD) 
values and used two-sample t test for statistical comparison of the experimental data.  
In cases of distributions different from normal, median, minimum and 
maximum values were calculated, and Mann-Whitney test was used.  
Comparisons between groups were performed with the Chi2-test for binary and 
categorical data. For analyzing a dataset in which there are one or more independent 
variables and dichotomous dependent variable, logistic regression [odds ratios (ORs) 
and 95% CI’s] was obtained to calculate adjusted ORs, and to assess the independent 
associations. Differences were considered statistically significant at p < 0.05. 
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3. RESULTS 
 
3.1. Results of platelet studies 
 
There was no significant difference between the average years of age in primary 
RS group (42.4 ± 10.0 years) vs. control group (41.6 ± 14.0 years). However, male to 
female ratio differed significantly (p<0.05) between patients (female/male: 158/42) and 
normal subjects (female/male: 77/39) and thus it was adjusted, when appropriate, to 
other parameters during statistical analyses. Serologic results for autoimmune diseases 
were negative in all PRP individuals. Hyperlipidemia ratio was similar (55 % vs. 47 %) 
in both groups, and no inflammatory process was detected by the measuring of CRP 
level and WBC count. 
 
Platelet count and mean volume 
Platelet (PLT) count was significantly lower in our primary RS patients 
compared with healthy controls (250 ± 4.6 ± 109/l vs. 268 ± 5.4 ± 109/l, p < 0.05).  
MPV was significantly increased in patients compared to clinical controls (11.0 
± 0.1 fl vs. 8.8 ± 0.1 fl, p < 0.001). Additionally, there was a significant and negative 
correlation between MPV and PLT count (R = −0.470, p < 0.001). 
 
Examination of CD62P expression 
The platelet CD62P expression was significantly increased value in primary RS 
patients compared to the control group (1,3 ± 1,1 % vs. 0,7 ± 1,1 %, p < 0,001). A 
significant positive correlation was found between CD62P expression of platelets and 
their numbers (R = 0,137, p = 0,032). 
 
Correlations between clinical data and laboratory results 
PLT counts, MPV and CD62P values were associated with neither the 
age/gender of patients nor the disease duration. Similar statistical significance (p < 
0.001) was calculated for MPV and CD62P levels when female and male patient 
subgroups were compared to female and male clinical controls. MPV values in total 
group were adjusted for PLT count and gender, and for PLT count in the female patient 
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group. Furthermore, adjustment for confounders did not influence the results. Adjusted 
ORs by multiple logistic regression analysis showed that both MPV (OR: 15.8, 95 % 
CI: 8.1–30.6) and CD62P (OR: 11.3, 95 % CI: 4.8–26.1) were significantly (p < 0.001) 
and independently related to primary RS during the analysis of either the whole patient 
cohort or in different gender subgroups, separately.  
During analysis, MPV values were adjusted for PLT and WBC counts in the total 
cohort and female subgroup, while CD62P was adjusted for PLT count and gender in 
total group, and for PLT count in female subgroup. Of note, 30.2 % of control group and 
98 % of patient group belonged to the upper tertile (> 49.3 fl) of MPV, whilst 33.6 % of 
controls and only 67 % of PRP subjects were in the upper tertile (> 0.99 %) in terms of 
CD62P positivity. 
 
 
3.2. Results of von Willebrand factor and fibrinogen studies  
 
No differences among groups were seen in vWF levels. Fibrinogen level, 
moderately but significantly, was elevated in female group (3.5 ± 0.8 g/L vs. 3.1 ± 0.8 
g/L, p = 0.016).  
 
Correlations between genders and laboratory results 
We defined vWF and fibrinogen levels according to tertiles and compared them 
separately. Fibrinogen level in the lowest tertile was significantly elevated in female 
group (p = 0.045) compared with male group. We obtained no significant difference of 
fibrinogen level among other tertiles between male and female groups. vWF level in the 
upper tertile [> 137.6%, odds ratio (95% confidence interval): 1.022 (0.466–2.239), p = 
0.958] did not confer a significant risk of primary RS between two groups of men and 
women. Neither fibrinogen in the upper tertile [> 3.8 g/L, odds ratio (95% confidence 
interval): 0.931 (0.333–2.608), p = 0.892] conferred any significant risk of primary RS 
between females and males. 
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3.3. Results of prothrombotic polymorphism analysis 
 
Based on anamntestic data, 29 % of primary RS patients suffered from migraine 
(n = 58). Duration of RS was significantly longer in patients with migraine than patients 
without migraine, in the whole group and when the two sexes were considered 
separately (p < 0.001). 
 
Prevalence of genetic polymorphisms 
Among all patients, 20 (10%) possessed the factor V Leiden allele polymorphism. 
Eighteen of these patients were heterozygous, and two were homozygous for the FV 
Leiden allele. Prevalence of the FII20210A allele polymorphism was 5%. No 
individuals homozygous for the FII20210A allele were detected. Interestingly, there 
was no MTHFR homozygous mutation among patients with migraine. The frequency of 
the T allele was significantly different between cases with migraine (50%) and without 
migraine (32%) (OR 2.1, 95% CI: 1.4–3.3, p = 0.001). Seventy-six cases (38%) were 
heterozygous for the FXIII V34L polymorphism, and 14 cases were homozygous for 
FXIII 34L (7%). A significantly higher allele frequency of MTHFR 677T in patients 
with PRP and migraine could be shown in this study. There was no correlation, 
however, between the occurrences of migraine and FIIG20210A, FVLeiden, or FXIII 
V34L mutations. 
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4. DISCUSSION 
 
4.1. Platelet studies in primary Raynaud's syndrome 
 
Several factors may contribute to the pathogenesis of primary RS, but the 
complex pathomechanism of this disease is still unknown. Among many conditions, 
alterations in hemostasis such as elevated levels of tissue plasminogen activator antigen, 
marked activation of GPIIb/IIIa receptor with increased thromboxane levels in platelets 
were formerly documented in patients with primary RS. Interestingly, conflicting data 
were published in terms of higher level of platelet-derived microparticles in the disease. 
However, the percentage of platelet-monocyte and platelet-neutrophil heterotypic 
aggregates were significantly elevated in primary RS patients compared to healthy 
controls. Overall, platelet hyperactivity and arterial thrombosis in the digits might be the 
part of disease etiology. 
MPV is a routinely measured platelet parameter by automated hematology 
analyzers, and its abnormal level may indicate altered platelet reactivity and potential 
vascular risk. MPV may increase due to the accelerated platelet turnover with higher 
level of reticulated platelets from bone marrow. According to previous publications, this 
marker with elevated levels predicted the development and progress of cardio- and 
cerebrovascular diseases or peripheral artery disease. MPV was higher than normal in 
severe dyslipidemia and diabetes mellitus as well. On the other hand, an increase in 
MPV has been also shown to be associated with hypertension. In other studies, changes 
in MPV have been linked to alterations in thrombogenesis, and the level of circulating 
autoantibodies and inflammatory agents. 
In the present study, MPV seems to reflect enlarged platelet reactivity as a 
potential cause or consequence of the development of primary RS, which was also 
demonstrated by CD62P positivity. Almost all patients (98%) belonged to the upper 
tertile of MPV, but it was 2/3 of the patient population in case of CD62P. MPV levels 
remained significantly higher in the total patient group or either gender subgroup 
compared to controls, even after adjustment for different confounders. Thus, MPV 
seems to be a more sensitive novel marker for PRP than CD62P. Future studies are 
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needed to examine the functional role of platelets with high MPV values in PRP with or 
without thrombotic events.  
In our study, significantly lower PLT count was observed in primary RS patients 
when compared to clinical controls suggesting that platelet consumption may be 
augmented in the disease due to their activation. Furthermore, megakaryocytes may be 
subsequently triggered to produce young and thus larger platelets. In contrast, elevated 
PLT count was measured in patients with RA versus non-RA subjects. This discrepancy 
might be due to the distinct pathophysiological function of activated platelets in the 
background of PRP and RA. These results support our hypothesis that elevated MPV is 
independently associated with PRP, but age, gender, and the disease duration do not 
alter this parameter. 
 
 
4.2. Studies on von Willebrand factor and fibrinogen 
 
Endothelium injuries lead to fibrin generation, in parallel, fibrinolytic system 
prevents excessive fibrin accumulation. Altered plasma fibrinolysis may contribute to 
the obstruction of free flow of blood, which is an important underlying mechanism of 
thrombotic vascular diseases. Previous studies on association between RS and vWF and 
fibrinogen levels were not only based on small number of subjects, but also their studies 
did not investigate this association between men and women separately, thus the 
possible relationship between these factors and primary RS remained controversial. Our 
data indicates that plasma levels of vWF and fibrinogen are not associated with primary 
RS in women or men. 
 
 
4.3. Prothrombotic polymorphism analysis 
 
The frequency of the prothrombotic risk factors FVLeiden mutation, FIII20210A 
mutation, and FXIII-A V34L polymorphism did not significantly differ in PRP patients 
with migraine and non-migrainous primary RS patients. Our results add to a series of 
recent reports on the relationship between FVLeiden and FII20210A genotypes and 
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migraine. As others, our data suggest that the factor XIII 34L allele does not play a 
protective role against migraine. 
It has been postulated that neurogenic and vascular hypotheses mostly explain 
the migraine. Neurogenic hypothesis predicts that neural events cause changes in blood 
flow. Cortical spreading depression which consists of slow dispersion wave of intensive 
neuronal burst activity and is followed by depression of spontaneous and evoked 
activity could activate trigeminal nerve. Vascular hypothesis explains the migraine 
attacks by alterations in the perivascular nerves of the cerebral vessels. It has been 
demonstrated that direct stimulation of the cerebral and meningeal blood vessels 
produced ipsilateral headaches. 
The enzyme MTHFR is responsible for the reduction of 5,10-methylene-THF to 
5-methyl-THF, the required substrate in the remethylation process. A homozygous 
mutation of the MTHFR gene, due to a point mutation 677 C to T changing alanine to 
valine at amino acid 222, has been related to thermolabile variant of the enzyme. This 
mutation causes hyperhomocysteinemia by reducing 5-MTH availability. Thermolabile 
MTHFR is the most frequent inherited defect of the Hcy pathway. Individuals 
homozygous for the MTHFR mutation have significantly higher Hcy levels than wild-
type or heterozygous ones. Hyperhomocysteinemia is an independent risk factor for 
cardiovascular diseases and it contributes to vascular damage by several mechanisms. It 
has direct toxic effect on endothelial cells and may strengthen the injury provoked by 
oxidative stress. Studies in humans and animals have shown negative effects of mild 
hyperhomocysteinemia on the blood vessels. Vascular endothelium dysfunction by 
homocysteine effect may influence migraine vulnerability through the activation of 
trigeminal nerve. The roles of elevated levels of Hcy on neurons have been reported to 
include generation of reactive oxygen species. In our patient group, the MTHFR 
mutation had significantly higher allele frequency in migrainous patients compared with 
patients without migraine. As the disease duration was significantly prolonged in 
patients with migraine, higher plasma Hcy levels for a longer period of time could affect 
blood vessels, consequently, it could lower the threshold of migraine headache in this 
group of patients. Thus, longer duration of primary RS and the presence of MTHFR 
677T allele could increase the risk of migraine headache. However, a former 
investigation revealed a significantly lower allele frequency of MTHFR 677T in 
21 
 
patients with PRP compared to healthy individuals. On the contrary, a number of studies 
reported higher allele frequency in patients suffering from migraine. So we cannot 
exclude that the increased frequency of MTHFR 677T allele is primarily associated with 
the migraine, regardless of the existing primary RS. 
Moreover, there is no rationale for premising that a thrombophilic state caused 
by the FVLeiden, FIIG20210A, and FXIII V34L mutations should be associated with 
migraine in primary RS. 
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5. THE NEW SCIENTIFIC RESULTS 
 
The results of our study on primary Raynaud’s syndrome (RS) indicate the 
involvement of altered platelet functions in the disease pathogenesis. We found 
significantly decreased platelet numbers in patients, compared to the results of healthy 
individuals. Regarding main platelet volume (MPV), we found significanty elevated 
values in the disease, moreover, the statistical analysis revealed a clear negative 
correlation between the aforementioned parameters. Of note, according to our data, 
CD62P expression was significantly elevated on platelets in primary RS, which 
indicates the activated state of the platelets. The increased MPV values also seem to 
reflect enlarged platelet reactivity as a potential cause or consequence of the 
development of primary RS. 
We did not found any alteration in plasma levels of von Willebrand factor or 
fibrinogen, which indicates that they are not associated with primary RS in women or 
men. 
Our investigations on prothrombotic polymorphisms revealed that the longer 
duration of primary RS and the presence of MTHFR 677T allele may increase the risk 
of migraine headache. Moreover, there is no rationale for premising that a 
thrombophilic state caused by the FV Leiden, FII G20210A and FXIII V34L mutations 
should be associated with migraine in primary RS. 
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